GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (FRA:PHS) » Definitions » Beneish M-Score

PhotoCure ASA (FRA:PHS) Beneish M-Score : -2.86 (As of Dec. 11, 2024)


View and export this data going back to 2018. Start your Free Trial

What is PhotoCure ASA Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.86 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for PhotoCure ASA's Beneish M-Score or its related term are showing as below:

FRA:PHS' s Beneish M-Score Range Over the Past 10 Years
Min: -3.37   Med: -2.71   Max: 0.02
Current: -2.86

During the past 13 years, the highest Beneish M-Score of PhotoCure ASA was 0.02. The lowest was -3.37. And the median was -2.71.


PhotoCure ASA Beneish M-Score Historical Data

The historical data trend for PhotoCure ASA's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Beneish M-Score Chart

PhotoCure ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.72 -2.40 -2.57 -2.88 -2.56

PhotoCure ASA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.79 -2.56 -2.70 -2.57 -2.86

Competitive Comparison of PhotoCure ASA's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Beneish M-Score falls into.



PhotoCure ASA Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PhotoCure ASA for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9329+0.528 * 0.9992+0.404 * 0.9257+0.892 * 1.108+0.115 * 0.823
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9188+4.679 * -0.090623-0.327 * 0.9536
=-2.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was €6.29 Mil.
Revenue was 10.197 + 12.729 + 10.233 + 12.391 = €45.55 Mil.
Gross Profit was 9.531 + 12.061 + 9.562 + 11.88 = €43.03 Mil.
Total Current Assets was €33.79 Mil.
Total Assets was €61.11 Mil.
Property, Plant and Equipment(Net PPE) was €1.84 Mil.
Depreciation, Depletion and Amortization(DDA) was €2.51 Mil.
Selling, General, & Admin. Expense(SGA) was €30.06 Mil.
Total Current Liabilities was €6.55 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Net Income was -0.294 + 1.079 + -0.684 + 1.146 = €1.25 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = €0.00 Mil.
Cash Flow from Operations was 2.929 + 1.709 + 0.44 + 1.707 = €6.79 Mil.
Total Receivables was €6.08 Mil.
Revenue was 9.396 + 12.338 + 9.421 + 9.955 = €41.11 Mil.
Gross Profit was 8.794 + 11.75 + 8.847 + 9.419 = €38.81 Mil.
Total Current Assets was €31.27 Mil.
Total Assets was €61.65 Mil.
Property, Plant and Equipment(Net PPE) was €2.61 Mil.
Depreciation, Depletion and Amortization(DDA) was €2.36 Mil.
Selling, General, & Admin. Expense(SGA) was €29.53 Mil.
Total Current Liabilities was €6.93 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6.287 / 45.55) / (6.082 / 41.11)
=0.138024 / 0.147945
=0.9329

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(38.81 / 41.11) / (43.034 / 45.55)
=0.944053 / 0.944764
=0.9992

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (33.791 + 1.839) / 61.11) / (1 - (31.266 + 2.614) / 61.647)
=0.416953 / 0.450419
=0.9257

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=45.55 / 41.11
=1.108

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.361 / (2.361 + 2.614)) / (2.505 / (2.505 + 1.839))
=0.474573 / 0.576657
=0.823

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(30.059 / 45.55) / (29.526 / 41.11)
=0.659912 / 0.718219
=0.9188

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 6.553) / 61.11) / ((0 + 6.932) / 61.647)
=0.107233 / 0.112447
=0.9536

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1.247 - 0 - 6.785) / 61.11
=-0.090623

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PhotoCure ASA has a M-score of -2.89 suggests that the company is unlikely to be a manipulator.


PhotoCure ASA Beneish M-Score Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PhotoCure ASA Business Description

Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.

PhotoCure ASA Headlines

No Headlines